VTRS vs ZBH: Which Stock Is the Better Buy?
Viatris Inc. and Zimmer Biomet Holdings, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — VTRS vs ZBH, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Viatris Inc. (VTRS) | Zimmer Biomet Holdings, Inc. (ZBH) | |
|---|---|---|
| Market cap | $20.4B | $18.2B |
| Revenue (latest FY) | $14.30B | $8.23B |
| Net income (latest FY) | $-3.51B | $705.10M |
| Revenue growth (5y CAGR) | 3.7% | 6.1% |
| Net margin | -24.6% | 8.6% |
| Return on equity | -23.9% | 5.6% |
| P/E ratio | — | 24.3 |
| Dividend yield | 2.7% | 1.0% |
| Profitable years (of last 10) | 4 | 8 |
| Positive free cash flow | Yes | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full VTRS vs ZBH breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open VTRS's full financials → Open ZBH's full financials →More comparisons
Frequently asked questions
Which is bigger, VTRS or ZBH?
Viatris Inc. is larger by market capitalization — $20.4B versus $18.2B.
Which grows faster, VTRS or ZBH?
Over the last five fiscal years, Zimmer Biomet Holdings, Inc. grew revenue faster — 6.1%/yr versus 3.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
VTRS fundamentals → · ZBH fundamentals → · All 1,500+ companies → · Free screener →